RIKEN VITAMIN CO., LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,607 JPY | -1.29% |
|
-4.12% | +16.64% |
| 02-29 | Riken Vitamin Buys Back Shares Worth Over 6 Billion Yen | MT |
| 02-29 | Riken Vitamin, Kikkoman End Raw Materials Partnership | MT |
Strengths
- With a P/E ratio at 9.31 for the current year and 10.84 for next year, earnings multiples are highly attractive compared with competitors.
Weaknesses
- The company's currently anticipated earnings per share (EPS) growth for the next few years is a notable weakness.
Ratings chart - Surperformance
Sector: Food Processing
| 1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
|---|---|---|---|---|
| +16.64% | 508M | - | - | |
| -2.39% | 275B | A- | ||
| -1.70% | 95.5B | C+ | ||
| -2.00% | 44.01B | C+ | ||
| +1.40% | 41.13B | B- | ||
| +9.84% | 41.41B | B- | ||
| +8.54% | 39.91B | B- | ||
| -12.79% | 31.14B | B- | ||
| -4.77% | 29.23B | A | ||
| +14.15% | 25.26B | A- |
Investor Rating
-
Trading Rating
-
ESG Refinitiv
-
Financials
Sales growth
Earnings Growth
EBITDA / Sales
-
Profitability
Finances
-
Valuation
P/E ratio
EV / Sales
-
Price to Book
-
Price to Free Cash Flow
-
Yield
Momentum
1 year Revenue revision
-
4 months Revenue revision
-
7 days Revenue revision
1 year EPS revision
-
4 months EPS revision
-
Consensus
Analyst Opinion
Potential Price Target
-
4m Target Price Revision
-
4m Revision of opinion
-
12m Revision of opinion
-
Business Predictability
Analyst Coverage
-
Divergence of Estimates
-
Divergence of analysts' opinions
-
Divergence of Target Price
-
Earnings quality
-
Technical analysis
ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
- Stock Market
- Equities
- 4526 Stock
- Ratings Riken Vitamin Co., Ltd.